2245711-25-3
2245711-25-3
Chemical Structure
Lauroyl-L-carnitine-d9 chloride
- CAS No.: 2245711-25-3
- Formula:C19H29D9ClNO4
- Molecular Weight:389.02
IUPAC Name: sodium octanoate-1-13C
InChIKey: PDBBUDRTWRVCFN-KIYCHUIWSA-N
SMILES: CCCCCCCCCCCC(O[C@H](CC(O)=O)C[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O.[Cl-]
Biological Activity: Lauroyl-L-carnitine-d9 chloride is the deuterium labeled Lauroyl-L-carnitine chloride (HY-130321). Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lauroyl-L-carnitine-d9 chloride | 98.0% | Lauroyl-L-carnitine-d9 chloride is the deuterium labeled Lauroyl-L-carnitine chloride (HY-130321). Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine-d3 hydrochloride | Lauroyl-L-carnitine-d3 (hydrochloride) is a deuterium labeled compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine-d3 chloride | 99.95% | Lauroyl-L-carnitine-d3 (chloride) is the deuterium labeled Lauroyl-L-carnitine chloride (HY-130321). Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine chloride | 99.92% | Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]
- [2]. Pei J, et al. Regulation of Plasma Metabolite-Inflammation Homeostasis Axes in IBD: Causal Evidence via Mendelian Randomization, in vivo and in vitro Validation[J]. Available at SSRN 5847951.
